Dolutegravir Medications

Dolutegravir Info

What is Dolutegravir?

Dolutegravir belongs to a class of medicines called integrase inhibitors. It is designed to stop the HIV virus from copying itself inside the body. By blocking this step, the drug helps keep the virus at low levels and supports the immune system. Dolutegravir is found in several approved products, most notably the tablet brand Tivicay.

Medications that contain Dolutegravir

In the United Kingdom, the primary medication that includes dolutegravir is Tivicay. Tivicay is supplied as a film-coated tablet, typically in a 50 mg strength. The product is marketed as a single-ingredient therapy, but it may also be combined with other antiretrovirals in fixed-dose tablets that are authorised for use. While generic versions are not yet widely available, the active ingredient is the same across all authorised preparations.

What does Dolutegravir treat?

• Human Immunodeficiency Virus (HIV) infection - Dolutegravir is prescribed for people living with HIV to reduce the amount of virus in the blood.
• Pre-exposure prophylaxis (PrEP) regimens - In some treatment plans, dolutegravir may be part of a combination used to prevent infection after a potential exposure.
• Therapeutic switching - Patients already on other antiretrovirals sometimes switch to a dolutegravir-based regimen for better viral control or to simplify therapy.

These uses are supported by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and reflect the drug’s ability to maintain low viral loads when taken as directed.

How Dolutegravir works

Dolutegravir stops the HIV integrase enzyme from inserting viral DNA into a person’s cells. By preventing this integration, the drug stops the virus from replicating efficiently. The effect begins shortly after the tablet is absorbed, and steady viral suppression can be achieved when the medication is taken regularly. This mechanism makes dolutegravir a powerful option for controlling HIV infection.

Safety information

Common side effects

• Mild nausea or stomach upset, often improving after a few days.
• Headache, which is usually brief and does not interfere with daily activities.
• Fatigue or tiredness, generally resolving without medical intervention.

These reactions are typical for many oral antiretroviral agents and are usually short-lived.

Serious reactions

• Signs of an allergic response, such as rash, itching, swelling of the lips or face, or difficulty breathing, require urgent medical attention.
• Unexplained fever, severe abdominal pain, or jaundice may indicate a more significant problem and should be reported promptly.

If any of these symptoms develop, seek immediate help from a healthcare professional.

Who should be cautious

• People with known hypersensitivity to dolutegravir or any component of the tablet should avoid it.
• Pregnant individuals should discuss the benefits and risks with their clinician, as the drug can cross the placenta.
• Those with serious liver disease may need special monitoring, as the liver processes many medications.

Interaction awareness

• Other antiretrovirals - Dolutegravir can interact with some protease inhibitors and non-nucleoside reverse-transcriptase inhibitors, potentially altering drug levels.
• Metal-containing antacids - Calcium, iron or magnesium supplements taken at the same time may reduce absorption; spacing them apart is advisable.
• Alcohol - Moderate consumption does not usually affect dolutegravir, but excessive intake can strain the liver and immune system.

For a full list of potential interactions, consult the information accompanying the specific product you are using.

What to know before using

Store dolutegravir tablets in a cool, dry place away from direct sunlight. Keep them out of reach of children and pets. The medication is generally intended for short- to long-term use, depending on the individual’s treatment plan. Always read the patient leaflet that comes with the product, as formulation details and instructions may differ between brands. For detailed usage, dosing, and administration, refer to the specific medication’s information.

Information disclaimer

This article offers general educational information about dolutegravir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing dolutegravir may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.